** Brokerage firm Morningstar believes real estate
investment trust Growthpoint's GOZ.AX revenue growth may
dampen due to rising finance costs until debt costs peak
** Fair value estimate for Growthpoint is A$3.80
** "Our assumptions include flat to down office rents in
fiscal 2024 (including the effect of incentives) and only a
gradual recovery" - Brokerage
** Morningstar says GOZ is in reasonable financial health,
but there are risks
** There is a risk Growthpoint may need to sell assets or
raise equity - brokerage
** Risk, however, is mitigated to a degree by leases, with a
weighted average expiry of over six years, Morningstar says
** GOZ down 16.8% YTD, as of last close
(Reporting by Adwitiya Srivastava in Bengaluru)
((Adwitiya.Srivastava@thomsonreuters.com;))